The prebiotic effect of α-1,2 branched, low molecular weight dextran in the batch and continuous faecal fermentation system

Journal of Functional Foods

Volumn 5, Issue 4, 2013, Pages 1938-1946

  Sarbini, Shahrul R ^a   Kolida, Sofia ^b   Naeye, Thierry ^c   Einerhand, Alexandra W ^c   Gibson, Glenn R ^b   Rastall, Robert A ^b  

^a DEPARTMENT OF CROP SCIENCE   (Malaysia)

^b UNIVERSITY OF READING   (United Kingdom)

^c Tate and Lyle Speciality Sweeteners   (United Kingdom)

Author keywords

Faecal fermentation; Gluco oligosaccharides; Gut microbiota; Prebiotics

Indexed keywords

BIFIDOBACTERIUM; BIFIDOBACTERIUM SP.; CLOSTRIDIUM HISTOLYTICUM; ENTEROCOCCUS; FAECALIBACTERIUM PRAUSNITZII; PREVOTELLA; ROSEBURIA;

EID: 84888437567     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2013.09.015     Document Type: Article

References (23)

1. Auriol D., Monsan P. Dextran and glucooligosaccharides. Bioprocesses and biotechnology for functional foods and nutraceuticals 2004, 120-133. Marcel Dekker, New York. F. Shahidi, J.-R. Neeser, J.B. German (Eds.).
2. Brison Y., et al. Synthesis of dextrans with controlled amounts of α-1,2 linkages using the transglucosidase GBDCD2. Applied Microbiology and Biotechnology 2010, 86(2):545-554.
3. Connolly M.L., Lovegrove J.A., Tuohy K.M. Konjac glucomannan hydrolysate beneficially modulates bacterial composition and activity within the faecal microbiota. Journal of Functional Foods 2010, 2(3):219-224.
4. Djouzi Z., et al. Degradation and fermentation of α-gluco-oligosaccharides by bacterial strains from human colon: In vitro and in vivo studies in gnotobiotic rats. Journal of Applied Microbiology 1995, 79(2):117-127.
5. Duncan S.H., Barcenilla A., Stewart C.S., Pryde S.E., Flint H.J. Acetate utilization and butyryl coenzyme A (CoA):Acetate-CoA transferase in butyrate-producing bacteria from the human large intestine. Applied and Environmental Microbiology 2002, 68(10):5186-5190.
6. Duncan S.H., Hold G.L., Harmsen H., Stewart C.S., Flint H.J. Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov. International Journal of Systematic and Evolutionary Microbiology 2002, 52(6):2141-2146.
7. Fukuda S., et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 2011, 469(7331):543-547.
8. Gibson G.R., et al. Dietary prebiotics: Current status and new definition. Food Science and Technology Bulletin: Functional Foods 2010, 7:1-19.
9. Goffin D., et al. Will isomalto-oligosaccharides, a well-established functional food in Asia, break through the European and American market? The status of knowledge on these prebiotics. Critical Review of Food Science and Nutrition 2011, 51:394-409.
10. Grimoud J., et al. In vitro screening of probiotic lactic acid bacteria and prebiotic glucooligosaccharides to select effective synbiotics. Anaerobe 2010, 16(5):493-500.
11. Hernot D.C., et al. In vitro fermentation profiles, gas production rates, and microbiota modulation as affected by certain fructans, galactooligosaccharides, and polydextrose. Journal of Agricultural and Food Chemistry 2009, 57(4):1354-1361.
12. Jia W., et al. Is the abundance of Faecalibacterium prausnitzii relevant to Crohn's disease?. FEMS Microbiology Letters 2010, 310(2):138-144.
13. Kaneko T., et al. Effects of isomaltooligosaccharides with different degrees of polymerization on human fecal bifidobacteria. Bioscience Biotechnology and Biochemistry 1994, 58(12):2288-2290.
14. Macfarlane G.T., Macfarlane S., Gibson G.R. Validation of a three-stage compound continuous culture system for investigating the effect of retention time on the ecology and metabolism of bacteria in the human colon. Microbial Ecology 1998, 35(2):180-187.
15. Olano-Martin E., Mountzouris K.C., Gibson G.R., Rastall R.A. In vitro fermentability of dextran, oligodextran and maltodextrin by human gut bacteria. British Journal of Nutrition 2000, 83(03):247-255.
16. Roberfroid M., et al. Prebiotic concept: Definition, metabolic and health benefits. British Journal of Nutrition 2010, 104:1-63.
17. Sanz M.L., CÔté G.L., Gibson G.R., Rastall R.A. Influence of glycosidic linkages and molecular weight on the fermentation of maltose-based oligosaccharides by human gut bacteria. Journal of Agricultural and Food Chemistry 2006, 54(26):9779-9784.
18. Sarbini S.R., Kolida S., Gibson G.R., Rastall R.A. In vitro fermentation of commercial α-gluco-oligosaccharide by faecal microbiota from lean and obese human subjects. British Journal of Nutrition 2013, 109(11):1980-1989.
19. Sarbini S.R., et al. In vitro fermentation of linear and alpha-1,2-branched dextrans by the human fecal microbiota. Applied and Environmental Microbiology 2011, 77(15):5307-5315.
20. Sarbini S.R., et al. In vitro fermentation of linear and α-1,2 branched dextans by the human faecal microbiota. Applied and Environmental Microbiology 2011, AEM.02568-10.
21. Sarbini S.R., Rastall R.A. Prebiotics: Metabolism, structure and function. Functional Food Reviews 2011, 3(3):93-106.
22. Valette P., et al. Bioavailability of new synthesised glucooligosaccharides in the intestinal tract of gnotobiotic rats. Journal of the Science of Food and Agriculture 1993, 62(2):121-127.
23. Walker A.W., Duncan S.H., McWilliam Leitch E.C., Child M.W., Flint H.J. PH and peptide supply can radically alter bacterial populations and short-chain fatty acid ratios within microbial communities from the human colon. Applied and Environmental Microbiology 2005, 71(7):3692-3700.